Kenvue's Distribution Challenges Pose a Near-Term Threat, but Our Long-Term Outlook Is Favorable
Despite the large debt balance compared with its current level of cash, we expect healthy cash generation from Kenvue to meet all of its near-term financial obligations. Only $1.5 billion of debt is ...
globalcosmeticsnews2d
US government mulls compensation claim against Johnson & Johnson
The US Department of Health & Human Services is considering a claim for compensation for the medical costs it has incurred ...
Pictured: Faces of the women with deadly cancer 'caused by talc' - as victims launch bid to sue Baby Powder maker Johnson & Johnson
Lawyers claim Johnson & Johnson knew that the product contained cancer causing asbestos, but failed to warn customers and continued to sell it until 2022.
Why Johnson & Johnson’s CEO Welcomes Scrutiny
Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.
HHS eyeing over $1B from J&J for talc cancer treatments: govt. attorney
Johnson & Johnson (JNJ) faces a $1B+ reimbursement demand for cancer cases linked to talc products. Read more here.